4.8 Article

Molybdenum Diphosphide Nanorods with Laser-Potentiated Peroxidase Catalytic/Mild-Photothermal Therapy of Oral Cancer

期刊

ADVANCED SCIENCE
卷 9, 期 1, 页码 -

出版社

WILEY
DOI: 10.1002/advs.202101527

关键词

chemodynamic therapy; mild-photothermal therapy; molybdenum diphosphide nanorods; oral cancer; peroxidase-like catalytic

资金

  1. Natural Science Foundation of Guangdong Province, China [2019A1515011911, 2020A1515010613]
  2. Key Basic Research Project of Shenzhen Science and Technology Program [JCYJ20200109140208058, JCYJ20200109115635440, JCYJ20200109115408041, JCYJ20190809104803572]
  3. Shenzhen-Hong Kong-Macau Technology Research Programme [SGDX2020110309300301]
  4. Shenzhen Fund for Guangdong Provincial High-Level Clinical Key Specialties [SZGSP008]
  5. Regional Joint Fund of the Guangdong Basic and Applied Basic Research Foundation [2020A1515111126]
  6. China Postdoctoral Science Foundation [2020M672872, 2021T140692]

向作者/读者索取更多资源

Chemodynamic therapy (CDT) is an emerging treatment that induces cell apoptosis or necrosis by decomposing hydrogen peroxide into a hydroxyl radical. This study introduces a new therapeutic approach using laser-potentiated peroxidase catalytic/mild-photothermal therapy of molybdenum diphosphide nanorods (MoP2 NRs) to improve CDT performance, achieving effective tumor eradication and anti-infection. Results demonstrate superior therapeutic efficiency with minimal toxicity, suggesting promising clinical applications.
Chemodynamic therapy (CDT) is an emerging treatment that usually employs chemical agents to decompose hydrogen peroxide (H2O2) into hydroxyl radical (center dot OH) via Fenton or Fenton-like reactions, inducing cell apoptosis or necrosis by damaging biomacromolecules such as, lipids, proteins, and DNA. Generally, CDT shows high tumor-specificity and minimal-invasiveness in patients, thus it has attracted extensive research interests. However, the catalytic reaction efficiency of CDT is largely limited by the relatively high pH at the tumor sites. Herein, a 808 nm laser-potentiated peroxidase catalytic/mild-photothermal therapy of molybdenum diphosphide nanorods (MoP2 NRs) is developed to improve CDT performance, and simultaneously achieve effective tumor eradication and anti-infection. In this system, MoP2 NRs exhibit a favorable cytocompatibility due to their inherent excellent elemental biocompatibility. Upon irradiation with an 808 nm laser, MoP2 NRs act as photosensitizers to efficiently capture the photo-excited band electrons and valance band holes, exhibiting enhanced peroxidase-like catalytic activity to sustainedly decompose tumor endogenous H2O2 to center dot OH, which subsequently destroy the cellular biomacromolecules both in tumor cells and bacteria. As demonstrated both in vitro and in vivo, this system exhibits a superior therapeutic efficiency with inappreciable toxicity. Hence, the work may provide a promising therapeutic technique for further clinical applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据